Isocorydine Targets the Drug-Resistant Cellular Side Population through PDCD4-Related Apoptosis in Hepatocellular Carcinoma

Isocorydine (ICD), an anticancer agent under current evaluation, decreased the percentage of side population (SP) cells significantly in hepatocellular carcinoma (HCC) cell lines. ICD treatment sensitized cancer cells to doxorubicin (DXR), a conventional clinical chemotherapeutic drug for HCC. We fo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lu, Ping, Sun, Hefen, Zhang, Lixing, Hou, Helei, Zhang, Lin, Zhao, Fangyu, Ge, Chao, Yao, Ming, Wang, Tingpu, Li, Jinjun
Format: Artigo
Idioma:Inglês
Publicat: ScholarOne 2012
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3474433/
https://ncbi.nlm.nih.gov/pubmed/22714713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2012.00055
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars